ARG66544
anti-MCM4 phospho (Ser54) antibody
anti-MCM4 phospho (Ser54) antibody for IHC-Formalin-fixed paraffin-embedded sections,Western blot and Human,Mouse,Monkey
Overview
Product Description | Rabbit Polyclonal antibody recognizes MCM4 phospho (Ser54) |
---|---|
Tested Reactivity | Hu, Ms, Mk |
Tested Application | IHC-P, WB |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Target Name | MCM4 |
Antigen Species | Human |
Immunogen | Phosphospecific peptide around Ser54 of Human MCM4. |
Conjugation | Un-conjugated |
Alternate Names | DHP; DPD; DHPDHASE; Dihydropyrimidine dehydrogenase [NADP(+)]; DHPDHase; DPD; EC 1.3.1.2; Dihydrothymine dehydrogenase; Dihydrouracil dehydrogenase |
Application Instructions
Application Suggestion |
|
||||||
---|---|---|---|---|---|---|---|
Application Note | IHC-P: Antigen Retrieval: High-pressure and temperature Tris-EDTA buffer (pH 8.0). * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Affinity purification with immunogen. |
Buffer | PBS, 0.02% Sodium azide, 50% Glycerol and 0.5% BSA. |
Preservative | 0.02% Sodium azide |
Stabilizer | 50% Glycerol and 0.5% BSA |
Concentration | 1 mg/ml |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Database Links |
Swiss-port # Q12882 Human Dihydropyrimidine dehydrogenase [NADP(+)] Swiss-port # Q8CHR6 Mouse Dihydropyrimidine dehydrogenase [NADP(+)] |
---|---|
Gene Symbol | DPYD |
Gene Full Name | dihydropyrimidine dehydrogenase |
Background | The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009] |
Function | Involved in pyrimidine base degradation. Catalyzes the reduction of uracil and thymine. Also involved the degradation of the chemotherapeutic drug 5-fluorouracil. [UniProt] |
Cellular Localization | Cytoplasm. [UniProt] |
Calculated MW | 111 kDa |